|
Group
|
Author
|
H&E positive
|
H&E negative
|
Sensitivity
|
Specificity
|
Concordance
|
|---|
|
OSNA negative
|
OSNA positive
|
OSNA negative
|
OSNA positive
|
|---|
|
1)
|
Tsujimoto et al. [15]
|
0.6 (2)
|
13.2 (43)
|
85 (276)
|
1.2 (4)
|
95.6
|
98.6
|
98.2 (319/325)
|
|
Feldman et al. [28]
|
3 (31)
|
10.2 (107)
|
83.1 (868)
|
3.6 (38)
|
77.5
|
95.8
|
93.4 (975/1044)
|
|
Le Frère-Belda et al. [29]
|
2.4 (12)
|
10.1 (51)
|
82.1 (413)
|
5.4 (27)
|
80.9
|
93.9
|
92.2 (464/503)
|
|
Vegué et al. [30]
|
0 (0)
|
1.1 (6)
|
92.1 (522)
|
6.9 (39)
|
100
|
93
|
93.1 (528/567)
|
|
Wang et al. [31]
|
2.6 (31)
|
13.4 (159)
|
78 (927)
|
6 (71)
|
83.7
|
92.9
|
91.4 (1086/1188)
|
|
Pathmanathan et al. [32]
|
1.8 (3)
|
14.7 (25)
|
80.6 (137)
|
3 (5)
|
89.3
|
96.5
|
95.3 (162/170)
|
|
Banerjee et al. [33]
|
0.7 (2)
|
14.6 (39)
|
81 (217)
|
3.7 (10)
|
95.1
|
95.6
|
95.5 (256/268)
|
|
Li et al. [34]
|
2 (6)
|
9.6 (30)
|
85.5 (266)
|
2.9 (9)
|
83.3
|
96.7
|
95.2 (296/311)
|
|
2)
|
Croner et al. [35]
|
1.6 (3)
|
20.1 (37)
|
75.5 (139)
|
2.7 (5)
|
92.5
|
96.5
|
95.7 (176/184)
|
|
Yamamoto et al. [36]
|
1 (4)
|
20.5 (79)
|
76.6 (295)
|
1.8 (7)
|
95.2
|
97.7
|
97.1 (374/385)
|
|
Guller et al. [37]
|
0.6 (2)
|
16.3 (51)
|
79.6 (249)
|
3.5 (11)
|
96.2
|
95.7
|
95.8 (300/313)
|
|
Yamamoto et al. [38]
|
1 (20)
|
6.5 (125)
|
89.2 (1717)
|
3.3 (63)
|
86.2
|
96.5
|
95.7 (1842/1925)
|
|
Yaguchi et al. [39]
|
3.1 (5)
|
24.7 (40)
|
69.8 (113)
|
2.5 (4)
|
88.9
|
96.6
|
94.4 (153/162)
|
|
Kumagai et al. [40]
|
2.3 (9)
|
11.4 (45)
|
82.7 (326)
|
3.6 (14)
|
83.3
|
95.9
|
94.2 (371/394)
|
|
Shimada et al. [41]
|
1.8 (8)
|
3.2 (14)
|
93.9 (412)
|
1.1 (5)
|
63.6
|
98.8
|
97 (426/439)
|
|
3)
|
Okamoto et al. [42]
|
2.3 (3)
|
2.3 (3)
|
93.8 (122)
|
1.5 (2)
|
50
|
98.4
|
96.2 (125/130)
|
|
Nagai et al. [43]
|
2.2(3)
|
10.2 (14)
|
86.9 (119)
|
0.7 (1)
|
82.4
|
99.2
|
97.1 (133/137)
|
|
Fanfani et al. [44]
|
0.9 (1)
|
7.2 (8)
|
86.4 (95)
|
5.4 (6)
|
88.9
|
94.1
|
93.6 (103/110)
|
|
Kost’un et al. [45]
|
0.7 (1)
|
7.4 (10)
|
78.5 (106)
|
13.3 (18)
|
90.9
|
85.5
|
85.9 (116/135)
|
|
4)
|
Inoue et al. [46]
|
0.6 (1)
|
11.5 (19)
|
87.3 (144)
|
0.6 (1)
|
95
|
99.3
|
98.8 (163/165)
|
|
Nakagawa et al. [47]
|
2.9 (12)
|
11.5 (47)
|
81.2 (333)
|
4.4 (18)
|
79.7
|
94.5
|
92.7 (380/410)
|
|
Escalante-Pérez et al. [48]
|
0.1 (1)
|
4.8 (34)
|
91.3 (644)
|
3.7 (26)
|
97.1
|
96.1
|
96.2 (678/705)
|
|
5)
|
Goda et al. [49]
|
2.6 (8)
|
17 (53)
|
77.2 (241)
|
3.2 (10)
|
86.9
|
96
|
94.2 (294/312)
|
|
Sofía del Carmen et al. [50]
|
5.2 (14)
|
28.1 (75)
|
60 (160)
|
6.7 (18)
|
84.2
|
89.9
|
88 (235/267)
|
|
6)
|
Engels et al. [24]
|
2.2 (12)
|
14.2 (76)
|
80.5 (452)
|
3.4 (18)
|
91.4
|
100
|
98.8 (528/534)
|
- Figures are expressed as percentages and (number of cases) in parentheses
- H&E Hematoxylin and eosin, No Number of, OSNA One-step nucleic acid amplification
